Table 1.

Clinico-pathological characteristics of EC patients analyzed for association with overall survival.

Patients	Total	P-value*	HR (95%CI)*
	N (%) 180 (100)
AGE
Median (IQR)	63 (56–69)		1
(Range)	(25–86)	0.14	1.01 (0.99–1.03)
GENDER
Male	147 (82)		1
Female	33 (18)	0.39	1.25 (0.75–2.10)
cSTAGE
II (B)	40 (22)		1
III (A-B-C)	131 (73)	0.73	1.53 (0.96–2.46)
IV (A)	9 (5)	0.30	1.55 (0.66–3.61)
HISTOTYPE
EADC	90 (50)		1
ESCC	90 (50)	0.31	1.22 (0.84–1.77)
TREATMENT
Neoadjuvant + surgery	134 (74)		1
Surgery	46 (26)	0.88	0.97 (0.64–1.48)
OS (MONTH)
Median (IQR)	29.5 (14–62)	-	-
(Range)	(4–108)

^*Cox proportional hazards methods.